Prenatal treatment of congenital adrenal hyperplasia: a promising experimental therapy of unproven safety.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Trends in endocrinology and metabolism

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1043-2760(98)00068-XPMID 18406286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.

  1997cited by this paper
• How safe is long-term prenatal glucocorticoid treatment?

  1997cited by this paper
• 11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess

  1997cited by this paper
• Serum Cortisol, Dehydroepiandrosterone Sulfate, and Steroid-Binding Globulins in Preterm Neonates: Effect of Gestational Age and Dexamethasone Therapy

  1996cited by this paper
• Gender change from female to male in classical congenital adrenal hyperplasia.

  1996cited by this paper
• Psychosexual development of women with congenital adrenal hyperplasia.

  1996cited by this paper
• Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study.

  1995cited by this paper
• Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency.

  1995cited by this paper
• Birth weight and blood pressure: cross sectional and longitudinal relations in childhood

  1995cited by this paper
• Prenatal diagnosis and management of congenital adrenal hyperplasia.

  1994cited by this paper
• Blood pressure in prospective population based cohort of newborn and infant twins

  1994cited by this paper
• Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency.

  1994cited by this paper
• Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation.

  1994cited by this paper
• Partnership and sexuality in adult female patients with congenital adrenal hyperplasia. First results of a cross-sectional quality-of-life evaluation.

  1993cited by this paper
• Prenatal diagnosis and treatment of 21-hydroxylase deficiency.

  1993cited by this paper
• Fetal nutrition and cardiovascular disease in adult life.

  1993cited by this paper
• Glucocorticoid exposure in utero: new model for adult hypertension.

  1993cited by this paper
• MUTATIONAL SPECTRUM OF THE STEROID 21-HYDROXYLASE GENE

  1993cited by this paper
• Prenatal diagnosis and successful intrauterine treatment of a female fetus with 21‐hydroxylase deficiency

  1992cited by this paper
• Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia.

  1992cited by this paper
• Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

  1992cited by this paper
• R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.

  1992cited by this paper
• Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.

  1992cited by this paper
• Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

  1991cited by this paper
• Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus.

  1990cited by this paper
• Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

  1990cited by this paper
• Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

  1990cited by this paper
• Newborn screening, prenatal diagnosis, and prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

  1990cited by this paper
• A missense mutation at Ile172----Asn or Arg356----Trp causes steroid 21-hydroxylase deficiency.

  1990cited by this paper
• Rearrangements and point mutations of P450c21 genes are distinguished by five restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia.

  1989cited by this paper
• Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: up-date 88 of the French multicentric study.

  1989cited by this paper
• The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities.

  1989cited by this paper
• The molecular genetics of 21-hydroxylase deficiency.

  1989cited by this paper
• Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency.

  1988cited by this paper
• Characterization of frequent deletions causing steroid 21-hydroxylase deficiency.

  1988cited by this paper
• P450XXI (steroid 21-hydroxylase) gene deletions are not found in family studies of congenital adrenal hyperplasia.

  1987cited by this paper
• Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

  1987cited by this paper
• Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.

  1984cited by this paper
• Age-related changes in endogenous steroids of human fetal testis during early and midpregnancy.

  1981cited by this paper
• Morphologic features of the anencephalic adrenal gland in early pregnancy.

  1980cited by this paper
• FUNCTIONAL PRENATAL DEVELOPMENT OF ANENCEPHALIC AND NORMAL ANTERIOR PITUITARY GLANDS

  1977cited by this paper
• Transport of ACTH across human placenta.

  1974cited by this paper
• Endocrine function in an anencephalic infant.

  1974cited by this paper
• The effect of adrenocorticotropic hormone and dexamethasone, administered to the fetus in utero, upon maternal and fetal eestrogens.

  1972cited by this paper
• Adrenals in Anencephaly and Hydrocephaly

  1956cited by this paper

• The Adrenal Cortex and its Disorders

  2019cites this paper
• [Steroid 21-hydroxylase deficiencies and female infertility: pathophysiology and management].

  2014cites this paper
• Déficits en 21-hydroxylase et infertilité féminine : de la physiopathologie à la prise en charge thérapeutique

  2014cites this paper
• Late prenatal dexamethasone and phenotype variations in 46,XX CAH: concerns about current protocols and benefits for surgical procedures.

  2014cites this paper
• Acute Encephalopathy with Unilateral Cortical-Subcortical Lesions in Two Unrelated Kindreds Treated with Glucocorticoids Prenatally for Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Established Facts and Novel Insight

  2013cites this paper
• Prenatal management of disorders of sex development.

  2012cites this paper
• The effect on the fetal pituitary-adrenal axis of dexamethasone administration early in the second trimester of pregnancy

  2011cites this paper
• Long-term follow-up of prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia

  2011cites this paper
• LONG-TERM FOLLOW-UP OF PRENATALLY DEXAMETHASONE-TREATED CHILDREN AT RISK FOR CONGENITAL ADRENAL HYPERPLASIA

  2011cites this paper
• Déficit en 21-hydroxylase: nouvelles démarches déduites des études moléculaires.

  2008cites this paper
• Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency).

  2005cites this paper
• Outcome of Prenatal Dexamethasone Treatment of Congenital Adrenal Hyperplasia

  2003cites this paper
• Pediatric Endocrinology

  2003cites this paper
• Dexamethasone does not exert direct intracellular feedback on steroidogenesis in human adrenal NCI-H295A cells.

  2003cites this paper
• Hiperplasia Suprarrenal Congénita: Revisão de 20 Casos da Consulta de Endocrinologia Pediátrica

  2003cites this paper
• [21 hydroxylase deficiency: new strategies emerging from molecular studies].

  2003cites this paper
• Regarding the consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology.

  2003cites this paper
• Consensus Statement on 21-Hydroxylase Deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology

  2003cites this paper
• Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.

  2003cites this paper
• Consensus Statement on 21-Hydroxylase Deficiency from The European Society for Paediatric Endocrinology and The Lawson Wilkins Pediatric Endocrine Society

  2002cites this paper
• Molecular genetics and epidemiology of steroid 21-hydroxylase deficiency. Origin of disease-causing mutations.

  2002cites this paper
• Management of Congenital Adrenal Hyperplasia: Results of the ESPE Questionnaire

  2002cites this paper
• Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology.

  2002cites this paper
• Congenital Adrenal Hyperplasia: From Genetics and Biochemistry to Clinical Practice, Part 2

  2001cites this paper
• Prenatal dexamethasone treatment of fetuses at risk for congenital adrenal hyperplasia: benefits and concerns.

  2001cites this paper
• Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia

  2000cites this paper
• Technical report: congenital adrenal hyperplasia. Section on Endocrinology and Committee on Genetics.

  2000cites this paper
• How Can Molecular Biology Contribute to the Management of Congenital Adrenal Hyperplasia?

  2000cites this paper
• How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency.

  2000cites this paper
• Congenital adrenal hyperplasia.

  2000cites this paper
• Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

  2000cites this paper
• Technical Report: Congenital Adrenal Hyperplasia

  2000cites this paper
• Defects in Aldosterone Biosynthesis

  2000cites this paper
• Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes.

  1999cites this paper
• Can Excess Glucocorticoid, in Utero, Predispose to Cardiovascular and Metabolic Disease in Middle Age?

  1999cites this paper
• Antenatal treatment for classic 21-hydroxylase forms of congenital adrenal hyperplasia and the issues

  1999cites this paper
• Society for Fetal Urology panel discussion: prenatal diagnosis and treatment of genital anomalies.

  1999cites this paper
• Prenatal Diagnosis and Treatment of 11β-Hydroxylase Deficiency Congenital Adrenal Hyperplasia Resulting in Normal Female Genitalia1

  1999cites this paper
• Adrenomedullary function is severely impaired in 21‐hydroxylase‐deficient mice

  1999cites this paper
• Disorders of the Aldosterone Synthase and Steroid 11β-Hydroxylase Deficiencies

  1999cites this paper
• Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.

  1999cites this paper
• Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety.

  1999cites this paper
• Can Excess Glucocorticoid, Predispose to Cardiovascular and Metabolic Disease in Middle Age?

  1999cites this paper
• Prenatal dexamethasone treatment does not prevent alterations of the hypothalamic pituitary adrenal axis in steroid 21-hydroxylase deficient mice.

  1999cites this paper
• Home monitoring of 17 hydroxyprogesterone levels: "throw away the urine jug, mom, the filter paper just arrived".

  1999cites this paper
• Congenital adrenal hyperplasia: molecular genetics and alternative approaches to treatment.

  1999cites this paper
• Prenatal treatment of congenital adrenal hyperplasia: a commentary.

  1998cites this paper
• American Academy of Pediatrics Section on Endocrinology and Committee on Genetics

  year unknowncites this paper